Safety and efficacy of moderate‐intensity statin with ezetimibe in elderly patients with atherosclerotic cardiovascular disease
Moderate-intensity statin with ezetimibe combination therapy offers a lower risk of SAMS and similar LDL-C reduction in elderly patients with ASCVD, compared to high-intensity statin monotherapy.
Authors
- Ju Hyeon Kim (ORCID: https://orcid.org/0000-0002-4193-0891)
- Jae Youn Moon (ORCID: https://orcid.org/0000-0001-8775-3539)
- Jae Hyoung Park (ORCID: https://orcid.org/0000-0001-8434-0157)
- Cheol Woong Yu (ORCID: https://orcid.org/0000-0002-5871-4562)
- Jung‐Joon Cha (ORCID: https://orcid.org/0000-0002-8299-1877)
- Do‐Sun Lim (ORCID: https://orcid.org/0000-0001-5751-5177)
- Hyung Joon Joo (ORCID: https://orcid.org/0000-0003-1846-8464)
- Cheol Whan Lee
- Soon Jun Hong (ORCID: https://orcid.org/0000-0003-4832-6678)
- Pil Hyung Lee (ORCID: https://orcid.org/0000-0001-7339-9188)
- Seung‐Whan Lee (ORCID: https://orcid.org/0000-0002-2662-5952)
- Jong‐Young Lee (ORCID: https://orcid.org/0000-0002-0092-9958)
- Jung‐Sun Kim (ORCID: https://orcid.org/0000-0003-2263-3274)
- Subin Lim (ORCID: https://orcid.org/0000-0002-8720-5484)
Institutions
- Ulsan College (KR)
- Yonsei University (KR)
- Severance Hospital (KR)
- Korea University Medical Center (KR)
- Asan Medical Center (KR)
- University of Ulsan (KR)
- Kangbuk Samsung Hospital (KR)
- CHA University Bundang Medical Center (KR)
- CHA University (KR)
- Incheon Medical Center (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Journal of Internal Medicine
- Published
- 2024-12-22
- DOI
- https://doi.org/10.1111/joim.20029
- Citations
- 5
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 2.86
Funders
- Yuhan